Tel Aviv Sourasky Medical Center is the main hospital complex serving Tel Aviv, Israel and its metropolitan area and the second-largest hospital complex in the country.

There are 1,171 beds in Department of Rheumatology, Tel Aviv Medical Center.

During the past decade, Department of Rheumatology, Tel Aviv Medical Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Rheumatology, Tel Aviv Medical Center" #1 collaborator was "Amsterdam Rheumatology and Immunology Center" with 1 trials as a collaborator, "Rambam Health Care Campus" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "University of California, Davis" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Department of Rheumatology, Tel Aviv Medical Center" are "Rheumatoid Arthritis" (4 trials), "Fibromyalgia" (1 trials), "Fibromyalgia Syndrome" (1 trials) and "Tocilizumab" (1 trials). Many other conditions were trialed in "Department of Rheumatology, Tel Aviv Medical Center" in a lesser frequency.

Most popular intervention types in "Department of Rheumatology, Tel Aviv Medical Center" are "Drug" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Duloxetine" (1 trials), "Inactivated split virion Influenza vaccine" (1 trials), "Leflunomide" (1 trials), "Methotrexate" (1 trials) and "Ocrelizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Rheumatology, Tel Aviv Medical Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Department of Rheumatology, Tel Aviv Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Department of Rheumatology, Tel Aviv Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Rheumatology, Tel Aviv Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".